Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Connolly

Showing results (831-840 of 1,370) with videos related to

Pageof 137
Sort By:
Journal of the American Medical Directors Association|April 1, 2011
Twenty-year trends in dependency in residential aged care in Auckland, New Zealand: a descriptive studyMichal Boyd, Joanna B Broad, Ngaire Kerse, et al.
Circulation. Cardiovascular Genetics|February 28, 2012
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular EventsGuillaume Paré, Stephanie Ross, Shamir R Mehta, et al.
Rheumatology (Oxford, England)|October 18, 2000
Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patientsE H Choy, D J Connolly, N Rapson, et al.
Clinical Neuropharmacology|January 1, 1991
The nicotinic receptor genesS Heinemann, J Boulter, J Connolly, et al.
The Annals of Thoracic Surgery|February 1, 1992
Granulocyte sequestration and early failure in the autoperfused heart-lung preparationC M Genco, R J Connolly, M B Peterson, et al.
American Heart Journal|October 31, 2006
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trialsGreg C Flaker, Michael Gruber, Stuart J Connolly, et al.
The New England Journal of Medicine|February 14, 2009
Effect of dronedarone on cardiovascular events in atrial fibrillationStefan H Hohnloser, Harry J G M Crijns, Martin van Eickels, et al.
Circulation|September 16, 2009
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutterStuart J Connolly, Harry J G M Crijns, Christian Torp-Pedersen, et al.
Clinical Biomechanics (Bristol, Avon)|December 14, 2011
An ex vivo biomechanical comparison of a novel vertebral compression fracture treatment system to kyphoplastyDerek C Wilson, Ryan J Connolly, Qingan Zhu, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.
Pageof 137

Showing results (831-840 of 1,370) with videos related to

Sort By:
Pageof 137
Journal of the American Medical Directors Association|April 1, 2011
Twenty-year trends in dependency in residential aged care in Auckland, New Zealand: a descriptive studyMichal Boyd, Joanna B Broad, Ngaire Kerse, et al.
Circulation. Cardiovascular Genetics|February 28, 2012
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular EventsGuillaume Paré, Stephanie Ross, Shamir R Mehta, et al.
Rheumatology (Oxford, England)|October 18, 2000
Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patientsE H Choy, D J Connolly, N Rapson, et al.
Clinical Neuropharmacology|January 1, 1991
The nicotinic receptor genesS Heinemann, J Boulter, J Connolly, et al.
The Annals of Thoracic Surgery|February 1, 1992
Granulocyte sequestration and early failure in the autoperfused heart-lung preparationC M Genco, R J Connolly, M B Peterson, et al.
American Heart Journal|October 31, 2006
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trialsGreg C Flaker, Michael Gruber, Stuart J Connolly, et al.
The New England Journal of Medicine|February 14, 2009
Effect of dronedarone on cardiovascular events in atrial fibrillationStefan H Hohnloser, Harry J G M Crijns, Martin van Eickels, et al.
Circulation|September 16, 2009
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutterStuart J Connolly, Harry J G M Crijns, Christian Torp-Pedersen, et al.
Clinical Biomechanics (Bristol, Avon)|December 14, 2011
An ex vivo biomechanical comparison of a novel vertebral compression fracture treatment system to kyphoplastyDerek C Wilson, Ryan J Connolly, Qingan Zhu, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.
Pageof 137